1. Modulation of butyrate transport in Caco-2 cells

   • Pedro Gonçalves
   • João Ricardo Araújo
   • Fátima Martel

   Original Article 21 November 2008 Pages: 325 - 336

   

2. Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)

   • Oliver Zolk
   • Thomas F. Solbach
   • Martin F. Fromm

   Original Article 11 November 2008 Pages: 337 - 348

   

3. Phosphorylation of phospholamban and troponin I through 5-HT₄ receptors in the isolated human atrium

   • Ulrich Gergs
   • Joachim Neumann
   • Stephanie Läer

   Original Article 11 November 2008 Pages: 349 - 359

   

4. Effects of gabapentin and pregabalin on K⁺-evoked ³H-GABA and ³H-glutamate release from human neocortical synaptosomes

   • B. Brawek
   • M. Löffler
   • T. J. Feuerstein

   Original Article 11 November 2008 Pages: 361 - 369

   

5. Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α₁- and α₁β-receptors

   • Jörg Ahrens
   • Martin Leuwer
   • Gertrud Haeseler

   Original Article 05 November 2008 Pages: 371 - 378

   

6. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (−)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium

   • Alejandro Galindo-Tovar
   • Maria Luisa Vargas
   • Alberto J. Kaumann

   Short Communication 14 November 2008 Pages: 379 - 384

   

7. How reliable are G-protein-coupled receptor antibodies?

   • Martin C. Michel
   • Thomas Wieland
   • Gozoh Tsujimoto

   Editorial Open access 27 January 2009 Pages: 385 - 388

8. Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice

   • Gitte Jositsch
   • Tamara Papadakis
   • Wolfgang Kummer

   Short Communication 31 October 2008 Pages: 389 - 395

   

9. Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors

   • Wisuit Pradidarcheep
   • Jan Stallen
   • Wouter H. Lamers

   Special Article Open access 07 February 2009 Pages: 397 - 402

   

10. Lack of specificity of antibodies directed against human beta-adrenergic receptors

    • Nazha Hamdani
    • Jolanda van der Velden

    Short Communication Open access 22 January 2009 Pages: 403 - 407

    

11. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific

    • Brian C. Jensen
    • Philip M. Swigart
    • Paul C. Simpson

    Special Article 07 November 2008 Pages: 409 - 412

    

12. Should we be cautious on the use of commercially available antibodies to dopamine receptors?

    • Serena Bodei
    • Nicola Arrighi
    • Sandra Sigala

    Short Communication 19 December 2008 Pages: 413 - 415

    

13. Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice

    • Xiaoying Lu
    • Tamas Bartfai

    Short Communication 22 January 2009 Pages: 417 - 420

    

14. Where is TRPV1 expressed in the bladder, do we see the real channel?

    • Wouter Everaerts
    • M. Rosario Sepúlveda
    • Dirk De Ridder

    Short Communication 20 January 2009 Pages: 421 - 425

    

15. Distribution and regulation of protein expression of the free fatty acid receptor GPR120

    • Satoshi Miyauchi
    • Akira Hirasawa
    • Gozoh Tsujimoto

    Original Article 15 January 2009 Pages: 427 - 434